Merck stock price ends higher ahead of Feb. 3 earnings — what MRK investors watch next week
Merck shares rose 1.8% to $110.27 Friday, outperforming the broader market. The company will report fourth-quarter and full-year results on Feb. 3, with investors focused on Keytruda’s growth, vaccine demand in China, and 2026 guidance. Trading volume was above average.